shots for weight loss tirzepatide Injections Chicago Affordable Tirzepatide (GLP-1) Injections for

Heres whats on the CBC Health Units watch list for 2026: New approaches to connecting people with family doctors, anticipated changes to cancer screening, misinformation and vaccine wariness, future uses for GLP-1 agonists (like Ozempic and Wegovy) and the morphing toxic drug crisis.

The degradation-resistant GLP-2-analog teduglutide has received approval for the treatment of SBS-IF, in which it may decisively reduce patient dependency on parenteral support and improve quality of life

Find out what's normal, when to worry, and how to manage symptoms in 2026.

Retatrutide is not FDA approved (April 2026)

Dual GIP/GLP-1 receptor agonist with step-up dosing from $368/month

Schedule your online visit now.